| Drug Type Gene editing | 
| Synonyms- | 
| Target | 
| Action inhibitors | 
| Mechanism LDHA inhibitors(L-lactate dehydrogenase A chain inhibitors) | 
| Therapeutic Areas | 
| Active Indication | 
| Inactive Indication- | 
| Originator Organization | 
| Active Organization | 
| Inactive Organization- | 
| License Organization- | 
| Drug Highest PhasePreclinical | 
| First Approval Date- | 
| Regulation- | 
| Indication | Highest Phase | Country/Location | Organization | Date | 
|---|---|---|---|---|
| Hyperoxaluria | Preclinical | United States  | 02 May 2019 | 





